NovMetaPharma Co., Ltd. (XKON:229500)
7,800.00
-150.00 (-1.89%)
At close: Jun 5, 2026
2.77% (1Y)
| Market Cap | 100.16B +3.8% |
| Revenue (ttm) | 1.30B +21.4% |
| Net Income | 408.03M |
| EPS | 120.00 |
| Shares Out | 12.84M |
| PE Ratio | 65.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,302 |
| Open | 7,950.00 |
| Previous Close | 7,950.00 |
| Day's Range | 7,800.00 - 8,200.00 |
| 52-Week Range | 6,800.00 - 17,890.00 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |